Delivery Order SPE2DB22D2211-SPE2DB25FSESZ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,037.83 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $7,473.80 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count) with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $6,313.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count package), with a completion date of July 22, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $12,436.60 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Entresto 24 mg-26 mg tablets (180 count). This competitive, firm fixed-price contract involves no set-aside designation and requires delivery by September 11, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29,471 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $22,232.86 to supply Entresto 97 mg-103 mg tablets (180-count) with an ultimate completion date of August 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare...
- The Defense Logistics Agency awarded a $1,295.96 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This firm fixed-price delivery order is non-competitive and will be completed by August 11, 2025, with performance originating from AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $22,550.03 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) under a firm fixed price contract type. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this procurement action. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,618.73 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price, competitively awarded delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSESZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,660.44 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count packaging) under a firm fixed price contract. This competitive award, effective September 11, 2025, with an ultimate completion date of September 12, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems. This specific delivery order for Entresto, a cardiovascular medication, exemplifies the company's ongoing role in providing critical brand-name pharmaceuticals to defense and veteran healthcare systems without set-aside designation, competing openly for placement on the DLA's medical supply contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 9/11/25 |